A Robust Classifier of High Predictive Value to Identify Good Prognosis Patients in ER-negative Breast Cancer

Breast Cancer Research - United Kingdom
doi 10.1186/bcr2138
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Identification of Prognosis-Relevant Subgroups in Patients With Chemoresistant Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2013English

Using the “Reverse Warburg Effect” to Identify High-Risk Breast Cancer Patients

Cell Cycle
MedicineDevelopmental BiologyCell BiologyMolecular Biology
2012English

MiRNAs Predict the Prognosis of Patients With Triple Negative Breast Cancer: A Meta-Analysis

PLoS ONE
Multidisciplinary
2017English

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Distinct P53 Gene Signatures Are Needed to Predict Prognosis and Response to Chemotherapy in ER-Positive and ER-Negative Breast Cancers

Clinical Cancer Research
Cancer ResearchOncology
2011English

Gene Expression-Based Predictive Markers for Paclitaxel Treatment in ER+ and ER− Breast Cancer

Frontiers in Genetics
GeneticsMolecular Medicine
2019English

A Clinicopathological Study and Prognosis of Node Negative Breast Cancer

The journal of the Japanese Practical Surgeon Society
1992English

Distinct Genes Related to Drug Response Identified in ER Positive and ER Negative Breast Cancer Cell Lines

PLoS ONE
Multidisciplinary
2012English

CHST9 Rs1436904 Genetic Variant Contributes to Prognosis of Triple-Negative Breast Cancer

Scientific Reports
Multidisciplinary
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy